electroCore FY2026 Earnings Forecast Lifted by HC Wainwright

Key Points

• HC Wainwright raised its FY2026 EPS forecast to a loss of $1.06 per share from a projected loss of $1.34. Its FY2026 estimate is also more optimistic than the $1.22-per-share loss consensus.
• electroCore reported a quarterly loss of $0.13 per share, narrower than the $0.27 loss analysts expected, but revenue of $9.69 million fell short of the $10.93 million consensus.
• Analyst views are mixed: the stock has an average Hold rating and an $18 consensus price target, with one Buy, one Hold, and one Sell rating.

electroCore, Inc. (NASDAQ:ECOR - Free Report) - Research analysts at HC Wainwright boosted their FY2026 earnings per share (EPS) estimates for shares of electroCore in a note issued to investors on Thursday, November 5th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings of ($1.06) per share for the year, up from their prior forecast of ($1.34). The consensus estimate for electroCore's current full-year earnings is ($1.22) per share. HC Wainwright also issued estimates for electroCore's Q4 2026 earnings at ($0.05) EPS, Q1 2027 earnings at ($0.05) EPS, Q2 2027 earnings at ($0.04) EPS, Q3 2027 earnings at ($0.04) EPS, Q4 2027 earnings at $0.05 EPS and FY2027 earnings at ($0.06) EPS.

Separately, Weiss Ratings reiterated a "sell (d-)" rating on shares of electroCore in a research report on Monday, September 21st. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $18.00.

electroCore Stock Performance

Shares of NASDAQ ECOR opened at $7.25 on Monday. The firm has a 50 day moving average of $9.28 and a 200 day moving average of $7.76. The firm has a market capitalization of $66.92 million, a price-to-earnings ratio of -5.22 and a beta of 1.23. electroCore has a 12-month low of $4.41 and a 12-month high of $12.70.

electroCore (NASDAQ:ECOR - Get Free Report) last issued its quarterly earnings data on Wednesday, November 4th. The company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.14. The business had revenue of $9.69 million during the quarter, compared to the consensus estimate of $10.93 million.

Institutional Trading of electroCore

An institutional investor recently bought a new position in electroCore stock. WealthShield Partners LLC bought a new stake in shares of electroCore, Inc. (NASDAQ:ECOR - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 25,978 shares of the company's stock, valued at approximately $157,000. WealthShield Partners LLC owned 0.32% of electroCore at the end of the most recent quarter. Hedge funds and other institutional investors own 26.74% of the company's stock.

Insiders Place Their Bets

In other electroCore news, CFO Joshua S. Lev sold 12,000 shares of the firm's stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $10.22, for a total transaction of $122,640.00. Following the sale, the chief financial officer directly owned 84,889 shares of the company's stock, valued at $867,565.58. This trade represents a 12.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Thomas Errico purchased 5,000 shares of the firm's stock in a transaction on Thursday, August 13th. The shares were acquired at an average cost of $9.85 per share, for a total transaction of $49,250.00. Following the completion of the acquisition, the director owned 343,332 shares of the company's stock, valued at approximately $3,381,820.20. This trade represents a 1.48% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders have sold 20,000 shares of company stock worth $200,120. 7.80% of the stock is owned by corporate insiders.

About electroCore

electroCore, Inc NASDAQ: ECOR is a commercial-stage medical device company focused on bioelectronic medicine and non-invasive vagus nerve stimulation (nVNS). Its technology is designed to stimulate the vagus nerve through the neck without requiring surgery or implanted components.

The company's primary prescription product is gammaCore, a handheld nVNS device used for the acute treatment of pain associated with migraine and episodic cluster headaches in adults. electroCore also markets consumer-oriented products, including Truvaga, a handheld vagus nerve stimulation device positioned for general wellness applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.